je.st
news
Tag: fda
FDA Requests Comments on Use of the Term 'Natural' on Food Labels
2015-11-10 21:08:00| Food Processing
The FDA is seeking comments from the public for the use of the term 'natural' in the labeling of human food products.
Tags: comments
food
term
natural
FDA Exploring \'Natural\'...in Food Labeling
2015-11-10 06:00:00| Happi Breaking News
What could this mean for personal care?
Tags: food
exploring
labeling
fda
Bright Plastics Receives FDA Approval of Cleanroom Facility
2015-11-09 11:31:08| Industrial Newsroom - All News for Today
Greensboro, NC Bright Plastics, Inc. a custom injection molding company has received the Food and Drug Administrations (FDA) approval for its cleanroom operations. Bright Plastics maintains an ISO 8, Class 100,000 cleanroom in which various products are produced for the medical industry in a carefully...
Tags: approval
facility
bright
receives
FDA Panel Backs Merck & Co Drug To Reverse Muscle Relaxant Effect
2015-11-07 20:15:36| Biotech - Topix.net
Merck & Co's drug to reverse the effects of muscle relaxants used in surgery is safe and effective enough to warrant approval, an independent panel to the U.S. Food and Drug Administration said. The drug, which goes by the chemical name of sugammadex, has repeatedly been rejected by the FDA due to concerns about potentially dangerous allergic reactions, even though it is approved in more than 75 countries.
Tags: effect
panel
drug
reverse
Merck Statement on FDA Advisory Committee Meeting for BRIDION (sugammadex), Investigational Agent for the Reversal of Neuromuscular Blockade (NMB) Induced by Rocuronium or Vecuronium
2015-11-06 20:13:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today issued the following statement after the conclusion of a meeting of the Anesthetic and Analgesic Drug Products Advisory Committee of the U.S. Food and Drug Administration (FDA) to discuss BRIDION (sugammadex). BRIDION is the proposed trade name for Mercks investigational agent for the reversal of neuromuscular blockade (NMB) induced by rocuronium or vecuronium. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Doris Li, 908-740-1903orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: or
statement
agent
meeting
Sites : [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] next »